XTL BIOPHARMACEUTICALS LTD. (XTLB) Net income 2015–2024
XTL BIOPHARMACEUTICALS LTD. (XTLB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.0MFY2024 · since FY2015: $2,000 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.0M | +42.4% |
| FY2023 | -$1.8M | -32.2% |
| FY2022 | -$1.3M | -409.9% |
| FY2021 | $435,000 | +114.7% |
| FY2020 | -$3.0M | -287.2% |
| FY2019 | -$763,000 | -121.0% |
| FY2018 | $3.6M | +564.8% |
| FY2017 | -$781,000 | +69.3% |
| FY2016 | -$2.5M | -127350.0% |
| FY2015 | $2,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice